You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 69 No. 1, January 2012 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Assessing Response to Stroke Thrombolysis

Validation of 24-Hour Multimodal Magnetic Resonance Imaging

Bruce C. V. Campbell, MBBS, BMedSc, FRACP; Hans T. H. Tu, MBBS, FRACP; Søren Christensen, PhD; Patricia M. Desmond, MD, FRANZCR; Christopher R. Levi, MBBS, FRACP; Christopher F. Bladin, MBBS, FRACP; Niels Hjort, MD, PhD; Mahmoud Ashkanian, MD; Christine Sølling, MD; Geoffrey A. Donnan, MD, FRACP; Stephen M. Davis, MD, FRACP; Leif Østergaard, DMSc, PhD; Mark W. Parsons, MBBS, PhD, FRACP

Arch Neurol. 2012;69(1):46-50. doi:10.1001/archneurol.2011.232

Background  Imaging is used as a surrogate for clinical outcome in early-phase stroke trials. Assessment of infarct growth earlier than the standard 90 days used for clinical end points may be equally accurate and more practical.

Objective  To compare assessment of the effect of reperfusion therapies using 24-hour vs day 90 magnetic resonance imaging.

Design  Infarct volume was assessed on diffusion-weighted imaging (DWI) at baseline and 24 hours after stroke onset and on fluid-attenuated inversion recovery images at day 90. The DWI and fluid-attenuated inversion recovery lesions were manually outlined by 2 independent raters, and the volumes were averaged. Interrater consistency was assessed using the median difference in lesion volume between raters.

Setting  Referral center.

Patients  Imaging data were available for 83 patients; 77 of these patients received thrombolysis.

Main Outcome Measures  Infarct volume at 24 hours and 90 days.

Results  The 24-hour DWI infarct volume had a strong linear correlation with day 90 fluid-attenuated inversion recovery infarct volume (r = 0.98, 95% confidence interval, 0.97-0.99). Recanalization had a significant effect on infarct evolution between baseline and 24 hours but not between 24 hours and day 90. Infarct growth from baseline was significantly reduced by recanalization, whether assessed at 24 hours or day 90. Infarct volume at either time point predicted functional outcome independent of age and baseline stroke severity. Interrater agreement was better for DWI than fluid-attenuated inversion recovery (1.4 mL [8%] vs 1.8 mL [17%]; P = .002).

Conclusions  Assessment of final infarct volume using DWI at 24 hours captures the effect of reperfusion therapies on infarct growth and predicts functional outcome similarly to imaging at day 90. This has the potential to reduce loss to follow-up in trials and may add early prognostic information in clinical practice.


Author Affiliations: Departments of Medicine (Drs Campbell, Tu, and Davis), Neurology (Drs Campbell, Tu, and Davis), and Radiology (Drs Campbell, Christensen, and Desmond), Royal Melbourne Hospital, and Florey Neuroscience Institutes (Dr Donnan), University of Melbourne, Parkville, Department of Neurology and Hunter Medical Research Institute, John Hunter Hospital, University of Newcastle, Newcastle (Drs Levi and Parsons), and Department of Neurology, Box Hill Hospital, Monash University, Melbourne (Dr Bladin), Australia; and Center of Functionally Integrative Neuroscience, Department of Neuroradiology, Århus University Hospital, Århus, Denmark (Drs Hjort, Ashkanian, Sølling, and Østergaard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2012 American Medical Association. All Rights Reserved.